Walking patterns help distinguish Lewy body dementia from Parkinson’s

Doctors often struggle to distinguish early dementia with Lewy bodies from early Parkinson's disease. The two neurological conditions share many symptoms, including changes in movement, and are frequently misdiagnosed in their early stages. New research from the University of Waterloo suggests that quantifying walking behavior might be a useful way to tell these diseases apart. 

The study found that people with early dementia with Lewy bodies walk more slowly, take shorter steps and have a lower walking rhythm than people with early Parkinson's disease. These differences were most pronounced when participants walked while performing a second task, such as counting backward. 

We compared stepping patterns between individuals with early dementia with Lewy bodies and people with early Parkinson's disease to see whether walking behavior could help distinguish the two conditions and found that they can. The findings highlight the promise of measuring movement in a more detailed manner which could address a significant clinical problem. Because the two diseases look similar in their early stages, patients may receive an incorrect diagnosis, which affects treatment decisions, care planning and expectations for patients and their families." 

Dr. Kaylena Ehgoetz Martens, professor in Waterloo's Department of Kinesiology and Health Sciences and lead author of the study

Simple yet quantitative walking assessments, which can be performed in clinical settings, could help clinicians diagnose patients more accurately and at an earlier stage. Earlier diagnosis may allow for earlier intervention, more targeted symptom management and clearer guidance for caregivers. 

While the researchers expected to see differences between the groups, one result stood out. 

"Walking without interference from a secondary task was less effective at identifying differences than walking while multitasking," Ehgoetz Martens said. "Asking participants to walk while counting backward revealed changes that weren't as obvious during regular walking. 

"Ultimately, the goal is to identify individuals sooner, intervene earlier and improve quality of life before symptoms become more severe." 

The results point to the importance of cognitive load - how attention and movement interact - in distinguishing neurological diseases that can otherwise appear similar. 

The work reflects the University of Waterloo's Health Futures focus, which brings together researchers across health, engineering and data science to develop practical, technology-enabled approaches to improving care. By translating everyday movement into meaningful clinical insight, the research highlights how accessible tools can support more equitable and accurate diagnosis. 

The researchers plan to expand their approach to other conditions and to people in the earliest, pre-clinical stages of disease, including those known to be at higher risk. 

Source:
Journal reference:

Mathias, K. D. A., et al. (2025). Differentiating gait behaviors between early-stage dementia with Lewy bodies and Parkinson’s disease. Gait & Posture. DOI: 10.1016/j.gaitpost.2025.110034. https://www.sciencedirect.com/science/article/pii/S0966636225007611?via%3Dihub

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Blood test marker p-tau217 helps detect early dementia risk in cognitively healthy older women